CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.571

Change

+0.04 (+0.74)%

Market Cap

USD 0.62B

Volume

6.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.30 (+0.69%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.30 (+0.06%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

+0.01 (+0.02%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.86 (-0.36%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.20 (+0.04%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.04 (+0.08%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.05 (-0.02%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.13 (+0.04%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

+0.27 (+0.26%)

USD 4.29B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.17% 56% F 68% D+
Dividend Return N/A 7% C- 4% F
Total Return N/A 1% F 7% C-
Trailing 12 Months  
Capital Gain 0.78% 16% F 44% F
Dividend Return N/A 54% F 8% B-
Total Return N/A 44% F 50% F
Trailing 5 Years  
Capital Gain -19.92% 9% A- 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.92% 7% C- 25% F
Average Annual (5 Year Horizon)  
Capital Gain -5.56% 8% B- 21% F
Dividend Return N/A 57% F 7% C-
Total Return N/A 21% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 6% D- 14% F
Risk Adjusted Return N/A 1% F 66% D+
Market Capitalization 0.62B 74% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.